AHAPS-functionalized silica nanoparticles do not modulate allergic contact dermatitis in mice

Nanoscale Research Letters

Volumn 9, Issue 1, 2014, Pages

  Ostrowski, Anja ^a   Nordmeyer, Daniel ^a   Mundhenk, Lars ^a   Fluhr, Joachim W ^b   Lademann, Jürgen ^b   Graf, Christina ^a   Rühl, Eckart ^a   Gruber, Achim D ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allergic contact dermatitis; Mouse model; Oxazolone; Silica nanoparticles; Toxicopathology

Indexed keywords

DERMATOLOGY; GENE TRANSFER; MAMMALS; MEDICAL APPLICATIONS; NANOPARTICLES; SILICA; SILICA NANOPARTICLES;

ALLERGIC CONTACT DERMATITIS; AMINOPROPYLTRIMETHOXYSILANE; DISTRIBUTION OF PARTICLES; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE MODELS; OXAZOLONE; TOXICOPATHOLOGY; TRANSEPIDERMAL WATER LOSS;

SIO2 NANOPARTICLES;

EID: 84907646699     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-9-524     Document Type: Article

References (27)

1. Wang L, Zhao W, Tan W: Bioconjugated silica nanoparticles: development and applications.Nano Res 2008, 1:99–115. 10.1007/s12274-008-8018-3
2. Combadière B, Mahé B: Particle-based vaccines for transcutaneous vaccination.Comp Immunol Microbiol Infect Dis 2008, 31:293–315. 10.1016/j.cimid.2007.07.015
3. Rahman A, Seth D, Mukhopadhyaya S, Brahmachary R, Ulrichs C, Goswami A: Surface functionalized amorphous nanosilica and microsilica with nanopores as promising tools in biomedicine.Naturwissenschaften 2009, 96:31–38. 10.1007/s00114-008-0445-1
4. Brandenberger C, Rowley N, Jackson-Humbles D, Zhang Q, Bramble L, Lewandowski R, Wagner J, Chen W, Kaplan B, Kaminski N, Baker GL, Worden RM, Harkema JR: Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice.Part Fibre Toxicol 2013, 10:26. 10.1186/1743-8977-10-26
5. Hirai T, Yoshikawa T, Nabeshi H, Yoshida T, Tochigi S, Ichihashi K, Uji M, Akase T, Nagano K, Abe Y, Kamada H, Itoh N, Tsunoda S, Yoshioka Y, Tsutsumi Y: Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection.Part Fibre Toxicol 2012, 9:3. 10.1186/1743-8977-9-3
6. Hirai T, Yoshikawa T, Nabeshi H, Yoshida T, Tochigi S, Uji M, Ichihashi K, Akase T, Yamashita T, Yamashita K, Nagano K, Abe Y, Kamada H, Tsunoda S, Yoshioka Y, Itoh N, Tsutsumi Y: Size-dependent immune-modulating effect of amorphous nanosilica particles.Pharmazie 2011, 66:727–728.
7. Hirai T, Yoshikawa T, Yoshida T, Ichihashi KI, Takahashi H, Nabeshi H, Yoshioka Y, Tsutsumi Y: Hazard identification of nanosilica particles using atopic dermatitis model mouse.Toxicol Lett 2012, 211:S199-S199.
8. Yoshida T, Yoshioka Y, Fujimura M, Yamashita K, Higashisaka K, Morishita Y, Kayamuro H, Nabeshi H, Nagano K, Abe Y, Kamada H, Tsunoda S, Itoh N, Yoshikawa T, Tsutsumi Y: Promotion of allergic immune responses by intranasally-administrated nanosilica particles in mice.Nanoscale Res Lett 2011, 6:195. 10.1186/1556-276X-6-195
9. Thyssen JP, Linneberg A, Menné T, Johansen JD: The epidemiology of contact allergy in the general population – prevalence and main findings.Contact Dermatitis 2007, 57:287–299. 10.1111/j.1600-0536.2007.01220.x
10. Isoda K, Hasezaki T, Kondoh M, Tsutsumi Y, Yagi K: Effect of surface charge on nano-sized silica particles-induced liver injury.Pharmazie 2011, 66:278–281.
11. Yoshida T, Yoshioka Y, Matsuyama K, Nakazato Y, Tochigi S, Hirai T, Kondoh S, Nagano K, Abe Y, Kamada H, Tsunoda S, Nabeshi H, Yoshikawa T, Tsutsumi Y: Surface modification of amorphous nanosilica particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA damage in various mammalian cells.Biochem Biophys Res Commun 2012, 427:748–752. 10.1016/j.bbrc.2012.09.132
12. Graf C, Gao Q, Schütz I, Noufele CN, Ruan W, Posselt U, Korotianskiy E, Nordmeyer D, Rancan F, Hadam S, Vogt A, Lademann J, Haucke V, Rühl E: Surface functionalization of silica nanoparticles supports colloidal stability in physiological media and facilitates internalization in cells.Langmuir 2012, 28:7598–7613. 10.1021/la204913t
13. Luo D, Saltzman WM: Nonviral gene delivery: thinking of silica.Gene Ther 2005, 13:585–586.
14. Funding AT, Johansen C, Gaestel M, Bibby BM, Lilleholt LL, Kragballe K, Iversen L: Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice.J Invest Dermatol 2008, 129:891–898.
15. Van Blaaderen A, Van Geest J, Vrij A: Monodisperse colloidal silica spheres from tetraalkoxysilanes: particle formation and growth mechanism.J Colloid Interface Sci 1992, 154:481–501. 10.1016/0021-9797(92)90163-G
16. Van Blaaderen A, Vrij A: Synthesis and characterization of colloidal dispersions of fluorescent, monodisperse silica spheres.Langmuir 1992, 8:2921–2931. 10.1021/la00048a013
17. Ostrowski A, Nordmeyer D, Boreham A, Brodwolf R, Mundhenk L, Fluhr JW, Lademann J, Graf C, Rühl E, Alexiev U, Gruber AD: Skin barrier disruptions in tape stripped and allergic dermatitis models have no effect on dermal penetration and systemic distribution of AHAPS-functionalized silica nanoparticles.Nanomedicine 2014. in press
18. Fluhr JW, Feingold KR, Elias PM: Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models.Exp Dermatol 2006, 15:483–492. 10.1111/j.1600-0625.2006.00437.x
19. Man M-Q, Hatano Y, Lee SH, Man M, Chang S, Feingold KR, Leung DYM, Holleran W, Uchida Y, Elias PM: Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.J Invest Dermatol 2007, 128:79–86.
20. Klopfleisch R, Deetzen M, Weiss AT, Weigner J, Weigner F, Plendl J, Gruber AD: Weigners fixative – an alternative to formalin fixation for histology with improved preservation of nucleic acids.Vet Pathol Online 2013, 50:191–199. 10.1177/0300985812441031
21. DaSilva S, Sahu R, Konger R, Perkins S, Kaplan M, Travers J: Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells.Arch Dermatol Res 2012, 304:65–71. 10.1007/s00403-011-1168-2
22. Proksch E, Brasch J: Abnormal epidermal barrier in the pathogenesis of contact dermatitis.Clin Dermatol 2012, 30:335–344. 10.1016/j.clindermatol.2011.08.019
23. Elias PM: Epidermal lipids, barrier function, and desquamation.J Invest Dermatol 1983, 80:44s-49s.
24. Yanagisawa R, Takano H, Inoue KI, Koike E, Sadakane K, Ichinose T: Size effects of polystyrene nanoparticles on atopic dermatitislike skin lesions in NC/NGA mice.Int J Immunopathol Pharmacol 2010, 23:131–141.
25. Yanagisawa R, Takano H, Inoue K-i, Koike E, Kamachi T, Sadakane K, Ichinose T: Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC/Nga mice.Bull Exp Biol Med 2009, 234:314–322. 10.3181/0810-RM-304
26. Fyhrquist N, Wolff H, Lauerma A, Alenius H: CD8+ T cell migration to the skin requires CD4+ help in a murine model of contact hypersensitivity.PLoS One 2012, 7:e41038. 10.1371/journal.pone.0041038
27. Christensen AD, Haase C: Immunological mechanisms of contact hypersensitivity in mice.APMIS 2012, 120:1–27.